Results 291 to 300 of about 3,690,314 (381)
Editorial: Pharmacotherapy of energy metabolism in obesity. [PDF]
Ussher JR.
europepmc +1 more source
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study
Abstract Objective Idiopathic intracranial hypertension (IIH) is a neurological disorder predominantly affecting young women with obesity, characterized by elevated intracranial pressure. While current treatments include weight loss counseling, medical therapies, and surgical interventions, their limitations necessitate exploring novel therapeutic ...
Ahmed Y. Azzam+13 more
wiley +1 more source
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation. [PDF]
Durairaj P, Liu ZL.
europepmc +1 more source
Skin calcium deposits in primary familial brain calcification: A novel potential biomarker
Abstract Objective Primary Familial Brain Calcification (PFBC) is a rare neurodegenerative disorder characterized by small vessel calcifications in the basal ganglia. PFBC is caused by pathogenic variants in different genes and its physiopathology is still largely unknown. Skin vascular calcifications have been detected in single PFBC cases, suggesting
Aron Emmi+8 more
wiley +1 more source
CYANIDE LOSS FROM MEDIA IN STUDIES OF TISSUE METABOLISM IN VITRO
Benjamin C. Riggs
openalex +1 more source
Disrupted fetal carbohydrate metabolism in children with autism spectrum disorder. [PDF]
Gumusoglu SB+4 more
europepmc +1 more source
ABSTRACTObjectiveCerebrospinal fluid (CSF) orexin‐A has been suggested to be a biomarker of Alzheimer disease (AD). In both cognitively unimpaired healthy older adults and individuals with symptomatic AD, CSF orexin‐A is positively associated with CSF Aβ42, p‐tau181, and total tau (t‐tau) concentrations.
Ruijin Lu+13 more
wiley +1 more source
Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy. [PDF]
Wan Y, Li G, Cui G, Duan S, Chang S.
europepmc +1 more source